Atlas Trials

Cambridge Antibody Technology

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Cambridge Antibody Technology

RecordFirmDate
Safety Study of CAT-8015 Immunoxin in Patients With NHL With Advance Disease (NCT00515892)Cambridge Antibody Technology2007-08-01
Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease (NCT00462189)Cambridge Antibody Technology2007-04-01
Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease (NCT00457860)Cambridge Antibody Technology2007-03-01

Track Cambridge Antibody Technology automatically

Every clearance here is in the API, with alerts when new ones post.